Agenus Inc. (AGEN), a clinical-stage immuno-oncology company, on Thursday, announced financial and clinical strategies designed to prioritize its core programs while implementing significant cost-cutting measures.
As part of the strategic realignment, the company has planned to reduce cash burn to $100 million in 2025, following the successful closing of a $22 million mortgage secured by key real estate assets.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.